|
|
|
|
|
|
|
Research Publications 2003
Abate MA, Stamatakis MS, Haggett RR. Excellence in curriculum development and assessment (invited paper). Am J Pharm Educ 2003;67(3; Article 89):1-21. Elliott, D.P., Atkinson,W.L., “The Use of the Cognitive Performance Scale to Identify Under and Over Treatment of Cognitive Deficits in Nursing Home Residents with Dementia”. The Consultant Pharmacist (2003) 18:368-372. Lucas, C.H., Terpening, C.M., Elliott, D.P., “Regarding the Management of Persistent Pain in Older Persons”. J Am Geriatr Soc (2003) 51:1045. Hare, J.T., Elliott, D.P., “Grapefruit Juice and its Drug Interactions”. The Consultant Pharmacist (2003) 18:466-472. Taylor, M.D., Antonini, J.M., Roberts, J.R., Leonard, S.S., Shi, X., Gannett, P.M., Hubbs, A.F., Reasor, M.J. “Intratracheal Amiodarone Administration to F344 Rats Directly Damages Lung Airway and Parenchymal Cells”, (2003) Am. J. Resp. Cell and Mol. Biol., 188:92-103. Gannett, P.M., Darian, E., van Tol, H., Dalal, N.S., "High Field Aqueous EPR of Spin Adducts and oligonucleotides", (2002) NHMFL 2002 Annual Research Review, Chemistry. Western, E.C., Daft, J.R., Johnson, II E.M. and Gannett, P.M., and Shaughnessy, K.H. (2003) J. Org. Chem 68:6767-6774. Gannett, P.M., Heavner, S., Daft, J.R., Shaughnessy, K., Epperson, J.D., Greenbaum, N.L. "Synthesis, Properties, and NMR Studes of a C-8 Phenylguanine Modified Oligonucleotide that Preferentially Adopts the Z-DNA Conformation." (2003) Chem. Res. Toxicol, 16:1385-1294. Gannett, P.M., Johnson, II, E.M., Grimes, M.A., Myers, A.L., Deavers, III, R.E., Tracy, T.S. (2003) “Synthesis of Deuterated 4,4'-Diaminodiphenylsulfone (Dapsone) and Related Analogs” J. Labelled Compds Radiopharmaceut, 46:107-114. E. H. Makela and R.K. Griffith, “Enhancing Treatment of Bipolar Disorder Using Patient’s Belief System”, Ann. Pharmacother., 2003, 37, 543-5. R. K. Griffith, “Anthelmintics”, in Burger’s Medicinal Chemistry and Drug Discovery, 6th Edition, Vol. 5, D. J. Abraham, editor, John Wiley & Sons, Inc., 2003, 1089-96. R.K. Griffith, “Adrenergics and Adrenergic Blocking Agents”, in Burger’s Medicinal Chemistry and Drug Discovery, 6th Edition, Volume 6, D. J. Abraham, editor, John Wiley & Sons, Inc., 2003, 1-37. Haining, R.L. and Yu, A. (2003) Cytochrome P450 Pharmacogenetics, in Cytochrome P450 and Drug Metabolism, J Lee, Ed., FontisMedia, pp. 343-387. Yu, A., Granvil, C.P., Haining, R.L., Krausz, K., Corchero, J., Kupfer, A., Idle, J.R. and Gonzalez, F.J. (2003) The relative contribution of monoamine oxidase and cytochromes P450 isozymes to the metabolic deamination of the trace amine tryptamine. J.Pharm.Exp.Ther. 304:539-546. SEQ CHAPTER \h \r 1Jacknowitz AI. A Pharmacict’s Guide to Counseling Patients Being Treated for Hepatitis C - Pharmacy Times 69 (5) 54, 56 (May 2003) Jacknowitz AI, Tracy TS. “Huperzine” in Cupp MJ, Tracy TS (eds) Dietary Supplements - Toxicology and Clinical Pharmacology Pages 245-252. Humana Press, Totowa, NJ (2003) Yin, X.J., Schafer, R., Ma, J.Y.C., Antonini, J.M., Weissman, D.D., Siegel, P.D., Barger, M.W., Roberts, J.R., Ma, J.K.H. Alteration of pulmonary immunity to Listeria monocytogenes by diesel exhaust particles (DEP). II. Effects of DEP on T cell-mediated immune responses. Environ. Health Perspect., 2003, 111:524-530. Rengasamy, A., Barger, M.W., Kane, E., Ma, J.K.H., Castranova, V., and Ma, J.Y.C. Diesel Exhaust Particle-Induced Alterations of Pulmonary Phase I and Phase II Enzymes of Rats. J. Toxicol. Environ. Health, 2003, 66, 153-167. Antonini, J.M., Roberts, J.R., Taylor, M.D., Yin, X.J., Stone, S., Moseley, A., Ma, J.K.H., Frazer, D.G., Castranova, V., Ma, J.Y.C. Effects of asphalt inhalation exposure at simulated road paving conditions prior to bacterial infection on lung defense responses in rats. Inhal Toxicol, 2003, 15:1347-1368. Madhavan SS, Rosenbluth SS, Amonkar MM, Fernandes AW, Borker R. "Immunization Predictors in Rural Adults Under 65 years of Age." J Health Care Poor Underserved. 2003; Vol. 14(1):100-121. Hassan M, Joshi AV, Madhavan SS, Amonkar MM. Obesity and Health Related Quality of Life: A Cross-sectional Analysis of the U.S. Population. Int J Obes. 2003;27:1227-32. Kamal KM, Madhavan SS, Maine LL. Pharmacy and Immunization Services: Pharmacists' Participation and Impact. J Am Pharm Assoc. 2003;43(4):470-82. Ndiaye S, Madhavan SS, Washington M, Shui I, Tucker J, Rosenbluth SA, Richards T. The Use of Pharmacy Immunization Services in Rural Communities. Public Health. 2003;117:88-97. Kamal KM, Madhavan SS, Amonkar MM. Determinants of Adult Influenza and Pneumonia Immunization Rates. J Am Pharm Assoc. 2003; 43(3): 403-411. Kamal KM, Madhavan SS, Maine LL. Impact of the American Pharmacists Association's (APhA) ImmunizationTraining Certification Program. Am J Pharm Educ. 2003; 67(4):article 124. Johnson JK, Madhavan SS, A Bibliography of Pharmacy Administration Master’s Theses and Doctoral Dissertations Relating to Education, 1993-2000. Journal of Pharmacy Teaching. 2003; Vol. 10(2):63-67 Johnson JK, Madhavan SS, A Bibliography of Pharmacy Administration Master’s Theses and Doctoral Dissertations, 1993-2000. J Pharm Mark Manage. 2003;Vol. 15(3):77-115 Madhavan SS, Direct-to-Consumer Advertising of Prescription Drugs – Editorial. Guest Editor of special issue on Direct to consumer advertising of Prescription Drugs. J Pharm Mark Manage. 2003;Vol. 15(3):3-5. Courses Offered at U.S. Colleges of Pharmacy. Published at National Community 4. Spinner T and Madhavan SS and 10 others. A Survey of Entrepreneurial Pharmacists Association website http://www.ncpanet.org/students/entrepreneurship.shtml" www.ncpanet.org/students/entrepreneurship.shtml and www.ncpanet.org/students/ent-wvu.shtml Kalsekar ID, Makela EH, Moeller KE. Analysis of West Virginia Medicaid claims data for the prevalence of medical conditions and use of drugs likely to cause QT prolongation in patients with schizophrenia. Current Therapeutic Research 2003;64:538-550. Schumacher JE, Makela EH, Griffin HR. Multiple antispychotic medication prescribing patterns. Annals of Pharmacotherapy 2003;37:951-5. Makela EH, Griffith RK. Enhancing treatment of bipolar disorder using patient's belief system. Annals of Pharmacotherapy 2003;37:543-45. Makela EH, Miller K, Cutlip WD. Modafinil use in treating sedation induced by antipsychotic medications. (letter) J Clinical Psychiatry 2003;64:485-86. Makela EH, Cutlip WD, Stevenson JM et al. Branded versus generic clozapine for treatment of schizophrenia. Annals of Pharmacotherapy 2003;37:350-53. Stevenson JP, Rosen M, Sun W, Gallagher M, Haller DG, Vaughn D, Giantonio B, Zimmer R, Petros WP, Stratford M, Chaplin D, Young SL, Schnall M, O'Dwyer PJ. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol. 2003 Dec 1; 21:4428-4438. Petros WP. Pegfilgrastim: A new era in the management of chemotherapy-induced neutropenia. Pharmacotherapy 2003;23:1S-2S. Williams D and Ponte CD. Warfarin-associated hypoprothrombinemia :an unusual presentation. Am J Health-Syst Pharm 2003;60:274-8. Wratchford P and Ponte CD. High-dose simvastatin and rhabdomyolysis. Am J Health-Syst Pharm 2003;60:698-700. Ponte CD and Wratchford P. Authors Reply - To Letter to the Editor regarding Wratchford P and Ponte CD. High-dose simvastatin and rhabdomyolysis. Am J Health-Syst Pharm 2003;60:698-700.(Published in Am J Health-Syst Pharm 2003;60:1791-92) Ye J, Wang L, Zhang X, Tantishaiyakul V, Rojanasakul Y. Inhibition of TNF-a gene expression and bioactivity by site-specific transcription factor binding oligonucleotides. Am J Physiol. 284:L386-L394, 2003. Wang L, Medan D, Mercer R, Overmiller D, Leornard S, Castranova V, Shi X, Ding M, Huang C, Rojanasakul Y. Vanadium-induced apoptosis and pulmonary inflammation in mice: Role of reactive oxygen species. J Cell Physiol. 195:99-107, 2003. Wang L, Antonini JM, Rojanasakul Y, Castranova V, Scabilloni JF, Mercer RR. Potential role of apoptotic macrophages in pulmonary inflammation and fibrosis. J Cell Physiol. 194:215-224, 2003. Nau DP, Scott VG, A Quality Improvement Program for Pharmacy-Based Diabetes Services In "Diabetes Management Services: A Pharmacist's Resource Guide". APhA Foundation, Washington, D.C. 2004, Chapter 3. > Stamatakis MK, Schreiber JM, Slain D, Gunel E. Vancomycin administration during dialysis with low-flux polysulfone membranes: Traditional versus a supplemental dosage regimen. Am J Health-Sys Pharm 2003;60:1564-8. Stamatakis MK, Schreiber JM, Slain D, Gunel E. Vancomycin administration during dialysis with low-flux polysulfone membranes: traditional versus a supplemental dosage regimen. Am J Health-Syst Pharm 2003;60:1564-8. Abate MA, Stamatakis MK, Haggett RR. Excellence in curriculum development and assessment. Am J Pharm Educ 2003;67(3):Article 15. Stamatakis MK. Chronic kidney disease. In: Pharmacotherapy self-assessment program, 4th edition. BA Mueller, K Bertch, T Dunsworth, S Fagan, et al. (eds.) American College of Clinical Pharmacy, Kansas City, MO, 2003. Liu, J., Ericksen, S.S., Besspiata, D., Fisher, C.W. and Szklarz, G.D. 2003. Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: case of residue 382. Drug Metab. Disp. 31:412-420.
|
||